Old Web
English
Sign In
Acemap
>
Paper
>
P210 Safety and effectiveness of lumacaftor-ivacaftor in cystic fibrosis patients with ppFEV1 ≤40% or ≥90%
P210 Safety and effectiveness of lumacaftor-ivacaftor in cystic fibrosis patients with ppFEV1 ≤40% or ≥90%
2020
Pierre-Régis Burgel
J. da Silva
Jean-Louis Paillasseur
Keywords:
Ivacaftor
Cystic fibrosis
Intensive care medicine
Medicine
Lumacaftor
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]